Kiran Mazumdar-Shaw

Shreehas

Pharma

Humira biosim clash not only about market share: Biocon exec

Three factors will determine the success of Biocon Biologics' Hulio, its CEO said. Those are pricing, supply and the delivery device.

Angus Liu Sep 20, 2023 8:25am

Kiran Mazumdar Shaw

Viatris sells biosimilar business to Biocon for $3.3B

Feb 28, 2022 4:57am

Bicon Managing Director Kiran Mazumdar-Shaw

Did Biocon's PE deal undervalue the spinoff-to-be biologics biz?

Jan 7, 2020 11:28am